HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing

Journal of Acquired Immune Deficiency Syndromes

Volumn 31, Issue 2, 2002, Pages 202-210

  Kellerman, Scott E ^a,e   Lehman, J Stan ^a   Lansky, Amy ^a   Stevens, Mark R ^a   Hecht, Frederick M ^c   Bindman, Andrew B ^c   Wortley, Pascale M ^b,d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CENTERS FOR DIS CONTR AND PREV   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HIV AIDS attitudes; HIV AIDS counseling and testing; HIV AIDS perceptions; HIV AIDS prevention

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ATTITUDE; DIAGNOSTIC TEST; FEMALE; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PERCEPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; STATISTICAL ANALYSIS; UNITED STATES;

EID: 0036800553     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200210010-00011     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention. Update: trends in AIDS incidence - United States, 1996. MMWR Morb Mortal Wkly Rep 1997;46:861-7.
2. Fleming PL, Wortley PM, Karon JM, et al. Tracking the HIV epidemic: current issues, future challenges. Am J Public Health 2000;90:1037-41.
3. Kamb ML, Fishbein M, Douglas JM, Jr, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA 1998;280:1161-7.
4. Weinhardt LS, Carey MP, Johnson BT, et al. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. Am J Public Health 1999;89:1397-405.
5. Wolitski RJ, Gomez C, Parsons J, et al. HIV-seropositive men's perceived responsibility for preventing the transmission of HIV to others [poster, abstract 23361]. Presented at the XII International Conference on AIDS, Geneva, June 1998.
6. Wolitski RJ, MacGowan RJ, Higgins DL, et al. The effects of HIV counseling and testing on risk-related practices and help-seeking behavior. AIDS Educ Prev 1997;9:52-67.
7. Centers for Disease Control and Prevention. HIV counseling and testing in publicly funded sites annual report, 1997 and 1998. Atlanta: Centers for Disease Control and Prevention, 2001:1-21.
8. Sweeney P, Wortley PM, Frey RL, et al. A minimum estimate of the number of living HIV infected persons confidentially tested in the United States. Presented at the XIII International AIDS Conference, Durban, South Africa, 2000.
9. Janssen RS, Holtgrave DR, Valdiserri RO, et al. The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. Am J Public Health 2001;91:1019-24.
10. Anderson J. The frequency of anonymous HIV testing in the United States: data from a national survey [letter]. AIDS 1999;13:1595-7.
11. Berrios D, Hearst N, Coates T, et al. HIV antibody testing among those at risk for infection. The National AIDS Behavioral Surveys. JAMA 1993;270:1576-80.
12. Roffman RA, Kalichman SC, Kelly JA, et al. HIV antibody testing of gay men in smaller US cities. AIDS Care 1995;7:405-13.
13. Maguen S, Armistead LP, Kalichman S. Predictors of HIV antibody testing among gay, lesbian, and bisexual youth. J Adolesc Health 2000;26:252-7.
14. Myers T, Orr K, Locker D, et al. Factors affecting gay and bisexual men's decisions and intentions to seek HIV testing. Am J Public Health 1993;83:701-4.
15. Anderson JE, Carey JW, Taveras S. HIV testing among the general US population and persons at increased risk: information from national surveys, 1987-1996. Am J Public Health 2000;90:1089-95.
16. Simon P, Weber M, Ford W, et al. Reasons for HIV antibody test refusal in a heterosexual sexually transmitted disease clinic population. AIDS 1996;10:1549-53.
17. Grinstead O, Peterson J, Faigeles B, et al. Antibody testing and condom use among heterosexual African Americans at risk for HIV infection: the National AIDS Behavioral Surveys. Am J Public Health 1997;87:857-9.
18. Samet J, Winter M, Grant L, et al. Factors associated with HIV testing among sexually active adolescents: a Massachusetts survey. Pediatrics 1997;100:371-7.
19. Anderson J. The frequency of anonymous HIV testing in the United States: data from a national survey [letter]. AIDS 1999;13:1595-7.
20. Anderson JF, Hardy AM, Cahill K, et al. HIV antibody testing and posttest counseling in the United States: data from the 1989 National Health Interview Survey. Am J Public Health 1992;82:1533-5.
21. Berrios D, Hearst N, Perkins L, et al. HIV antibody testing in young, urban adults. Arch Intern Med 1992;152:397-402.
22. Hecht FM, Chesney M, Lehman JS, et al. Does HIV reporting by name deter testing? AIDS 2000;14:1801-8.
23. SAS [computer program]. Version 6.12. Cary, NC: SAS Institute, 1990.
24. Epi Info [computer program]. Version 6.04. Atlanta: Centers for Disease Control and Prevention, 1999.
25. Collier A, Coombs R, Schoenfeld D, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med 1996;334:1011-7.
26. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997;337:725-33.
27. Hammer SM, Katzenstein DA, Hughes MD, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team [see comments]. N Engl J Med 1996;335:1081-90.
28. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA 1996;276:146-54.
29. Dworkin MS, Wan PCT. Surveillance of antiretroviral prescriptions. J Acquir Immune Defic Syndr 2000;24:294.
30. Koblin BA, Torian LV, Guilin V, et al. High prevalence of HIV infection among young men who have sex with men in New York City. AIDS 2000;14:1793-800.
31. Waldo CR, McFarland W, Katz MH, et al. Very young gay and bisexual men are at risk for HIV infection: the San Francisco Bay Area Young Men's Survey II. J Acquir Immune Defic Syndr 2000;24:168-74.
32. Valleroy LA, MacKellar DA, Karon JM, et al. HIV prevalence and associated risks in young men who have sex with men. Young Men's Survey Study Group. JAMA 2000;284:198-204.
33. Centers for Disease Control and Prevention. HIV counseling and testing in publicly funded sites annual report, 1997 and 1998. Available at: http://www.cdc.gov/hiv/pubs/cts98.pdf. Accessed June 19, 2001.
34. Centers for Disease Control and Prevention. 2001. HIV prevention strategic plan through 2005. Available at: http://www.cdc.gov/nchstp/od/news/prevention.pdf. Accessed March 30, 2001.